Matrix metalloproteinase-9 (MMP-9) is an extracellular protease that is induced in Schwann cells hours after peripheral nerve injury and controls axonal degeneration and macrophage recruitment to the lesion. Here, we report a robust (90-fold) increase in MMP-9 mRNA within 24 h after rat sciatic nerve crush (1 to 60 days time-course). Using direct injection into a normal sciatic nerve, we identify the proinXammatory cytokines TNF-and IL-1 as potent regulators of MMP-9 expression (Taqman qPCR, zymography). Myelinating Schwann cells produced MMP-9 in response to cytokine injection and crush nerve injury. MMP-9 gene deletion reduced unstimulated neuropathic nociceptive behavior after one week post-crush and preserved myelin thickness by protecting myelin basic protein (MBP) from degradation, tested by Western blot and immunoXuorescence. These data suggest that MMP-9 expression in peripheral nerve is controlled by key proinXammatory cytokine pathways, and that its removal protects nerve Wbers from demyelination and reduces neuropathic pain after injury.
Introduction
Neuropathic pain is often a consequence of neuropathological and molecular changes resulting from peripheral nerve damage. Complex interactions of injured peripheral nerve Wbers with activated glia (Schwann cells) and recruited immune cells is regulated by a number of immunomodulatory and trophic factors. ProinXammatory cytokines, such as tumor necrosis factor alpha (TNF-) and interleukins (IL-1 , IL-6), have been implicated in the pathogenesis of Wallerian degeneration and neuropathic pain, as they control axonal demyelination, degeneration, bloodnerve permeability, and immune cell recruitment (Stoll et al., 2002) , and thus, represent model therapeutic targets in neuropathic pain (Myers et al., 2006) . Recently, we have shown that some critical actions of TNF-in injured nerve, such as macrophage recruitment, are mediated by matrix metalloproteinase-9 (MMP-9 or gelatinase B) (Shubayev et al., 2006) . MMP-9 belongs to a family of Zn 2+ -dependent extracellular proteases called matrix metalloproteinases (MMPs), that comprise collagenases, gelatinases, stromelysins, and membrane-type MMPs (Woessner, 1994) . In the nervous system, MMPs produce neuroinXammation by controlling neurovascular permeability, immune cell recruitment, demyelination, cell necrosis, and apoptosis (Yong et al., 1998; Kieseier et al., 1999b , Rosenberg, 2002 Lee et al., 2004a , Yong, 2005 . MMP-9 is upregulated in experimental peripheral neuropathy models (La Fleur et al., 1996; Kherif et al., 1998; Ferguson and Muir, 2000; Siebert et al., 2001; Hughes et al., 2002; Platt et al., 2003; Demestre et al., 2004) and in patients with symptomatic neuropathy (Leppert et al., 1999; Mawrin et al., 2003; Renaud et al., 2003; Gurer et al., 2004) . We have recently shown that MMP-9 gene
